Literature DB >> 24666094

Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children.

Claudia Pasqualini1, Veronique Minard-Colin, Veronique Saada, Laurence Lamant, Georges Delsol, Catherine Patte, Marie-Cécile Le Deley, Dominique Valteau-Couanet, Laurence Brugières.   

Abstract

Haemophagocytic lymphohistiocytosis (HLH) has been rarely described in children treated for an anaplastic large-cell lymphoma (ALCL). We evaluated the incidence, the clinical and histological characteristics and the prognosis of HLH associated-ALCL. The medical, biological, cytological and histological data of patients treated for ALK-positive ALCL in the paediatric department of a single institution between 1975 and 2008 were analysed and assessed for HLH according to diagnosis criteria of the Histiocyte Society. Data concerning a series of 50 consecutive children with ALCL were reviewed. HLH-associated ALCL was observed in 12% of the patients. Lung involvement was significantly more frequent in HLH-associated ALCL patients than in the group without HLH (P = 0·004), as well as central nervous system (CNS) and bone marrow involvement (P = 0·001 and P = 0·007 respectively). The histological subtype in children with HLH-associated ALCL did not differ from that of the group without HLH. There was no significant difference between the two groups in 5-year EFS and OS (P = 0·91 and P > 0·99 respectively). In conclusion, HLH is not rare in paediatric ALCL. Despite a high incidence of visceral, CNS and bone marrow involvement, HLH does not seem to exert a significant impact on outcome in children treated for ALCL.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  anaplastic large cell lymphoma; child; haemophagocytic lymphohistiocytosis; haemophagocytosis; perforin

Year:  2014        PMID: 24666094     DOI: 10.1111/bjh.12728

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Minimal Change Disease as Initial Presentation of ALK-Positive Anaplastic Large-Cell Lymphoma in a Pediatric Patient.

Authors:  Karla Diaz; William Slayton; Nirupama Gupta
Journal:  Case Rep Oncol       Date:  2017-11-06

Review 2.  Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

Authors:  Serena Stadler; Vijay Kumar Singh; Fabian Knörr; Christine Damm-Welk; Wilhelm Woessmann
Journal:  Cancers (Basel)       Date:  2018-04-10       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.